Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJG4Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $107,492
Award facts
- Contract value 100% obligated
- $107,491.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $107,491.84 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 6, 2026, for the supply of Dupixent 300 mg/2 mL pen injections. This firm fixed-price delivery order, which carries an ultimate completion date of January 7, 2026, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was awarded on a competitive, non-set-aside basis and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.9 million through December 2031.
Dupixent is a biologic medication used to treat various inflammatory conditions including atopic dermatitis, asthma, and eosinophilic esophagitis, making it a critical pharmaceutical commodity for military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical supply requirements across multiple therapeutic domains through its comprehensive relationship with the DLA. The delivery order demonstrates the contractor's ongoing capability to supply specialized brand-name medications to support the Defense Health Agency and other federal healthcare programs on a rapid fulfillment basis.
Quick answers
Who was awarded contract SPE2DR26FJG4Q?
SPE2DR26FJG4Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FJG4Q worth?
The government has obligated $107,492 on SPE2DR26FJG4Q.
Is contract SPE2DR26FJG4Q an order under another contract?
Yes. SPE2DR26FJG4Q is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG4Q competed?
The extent of competition for SPE2DR26FJG4Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award